Partnership between Camgenium and Cardiac Tech to enhance recovery after cardiac surgery using Pace-Protect system technology
In the realm of cardiac medical devices, a groundbreaking innovation is on the horizon. Camgenium, a leading medical software engineering company, and Cardiac Tech, a MedTech innovator, have joined forces to develop Pace-Protect - a safety device designed to address the unmet need for safer temporary pacemakers.
Pace-Protect is set to revolutionise the management of temporary pacemakers, particularly following open-heart surgery. Research indicates that there are roughly 1,500 serious adverse events (SAEs) reported each year in the US alone, attributable to the management of these devices. The Pace-Protect system aims to prevent such SAEs by providing real-time monitoring and alerts.
The Pace-Protect system establishes world-class data security for patient confidentiality and high resilience, ensuring individual devices never lose contact with the cloud. This is made possible through Soft Silicon mesh network technology, a highly sophisticated architecture for communications that uses Bluetooth Low Energy (BLE) and Wi-Fi, cellular, Near Field Communication (NFC), and Long Range (LORA) technologies.
The functioning Pace-Protect prototype adheres to ISO 13485 and IEC 62304 Class IIa standards, ensuring it meets the highest quality and safety standards for medical devices.
One of the key features of Pace-Protect is its ability to allow real-time patient electrogram (EGM) data to be transmitted to the clinical team at high data rates in emergencies. This real-time data transmission can potentially improve patient outcomes following open-heart surgery by minimising adverse events related to temporary pacemakers.
The Pace-Protect device, designed for safer temporary pacemakers, is slated to be the first device using a Soft Silicon mesh network to be deployed in a clinical environment. The device's communications electronics, including those in the physical system, the cloud-based platform, and the app, have been developed by Camgenium.
While no public updates specifically on the Pace-Protect medical device have been found as of August 2025, the pacemaker market is expected to grow significantly, driven by innovations such as leadless devices, remote monitoring, MRI-safe technology, and AI-powered features. Regulatory agencies are also streamlining medical device approvals, which could accelerate the entry of devices like Pace-Protect to market.
For precise updates on Pace-Protect, contacting the manufacturers directly or consulting specialized cardiology device publications and clinical trial registries may be necessary.
- Collaborative efforts between Camgenium and Cardiac Tech are focused on enhancing digital health by designing Pace-Protect, a safety device for temporary pacemakers that addresses medical-conditions related to cardiovascular-health, particularly following open-heart surgery.
- Pace-Protect, equipped with real-time monitoring and alert systems, aims to reduce the reported 1,500 serious adverse events (SAEs) annually in the US, which are associated with the management of temporary pacemakers, by leveraging science and technology for health-and-wellness improvements.
- Pace-Protect is not only slated to be the first device using a Soft Silicon mesh network to be deployed in a clinical environment but also sets new standards in data security for digital health, employing ISO 13485 and IEC 62304 Class IIa safety and quality regulations.
